Archive for June, 2011

FDA warns of Depakote link to lower IQ scores

The Food and Drug Administration has warned that children whose mothers used Depakote or similar drugs during pregnancy are more likely to have lower cognitive test scores than those who were exposed to other anti-seizure medications. In addition to its use on seizures, Depakote is also prescribed to treat bipolar disorder and migraine headaches.

Click here to read more…

In Medicine, New Isn’t Always Improved

A type of implants, known as metal-on-metal hips, were regarded by device makers and surgeons as a major advance over previous designs that used both metal and plastic. Now federal regulators and medical researchers are scrambling to determine how many implant recipients have been injured by the devices, which can shed dangerous metallic debris through wear.

Click here to read more…

Zoloft Birth Defects Lawyers Website Launched by Hissey Kientz, LLP

The law firm of Hissey Kientz, LLP announces the launch of its new website, Zoloft Birth Defects Lawyers (http://www.zoloftbirthdefectslawyers.com/). The new site will serve as a news and information resource for women and their families who have been affected by birth defects linked to the use of Zoloft during pregnancy.

Click here to read more…

Some small risks to antidepressants in pregnancy

Two antidepressants appear to be associated with a small risk of birth defects, according to a new analysis based on national data from Finland. Specifically, the researchers found that women taking fluoxetine (Prozac) and paroxetine (Paxil) were slightly more likely to give birth to babies with specific types of heart defects.

Click here to read more…

Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos

Bristol-Myers Squibb and AstraZeneca’s new diabetes pill will probably face increased scrutiny from regulators and doctors after two rivals were tied to cancer and heart risks. The drug, dapagliflozin, works differently than Takeda Pharmaceutical’s Actos, linked to cancer last week, and GlaxoSmithKline’s Avandia, tied to heart risks in 2007.

Click here to read more…

Silicone is safe, FDA says (besides, options are few)

The Food and Drug Administration is essentially telling U.S. consumers worried about silicone breast implants: “Told you so.” But in releasing new research backing up its 2006 decision to allow the implants back onto the market, the agency also reminds women, in a way, that they have only two choices — silicone or saline. Until 2006, silicone implants had been under a 14-year ban by the FDA because of concerns that leaks or ruptures could increase the risk of certain diseases.

Click here to read more…

Generic-Drug Makers Shielded From Lawsuits, Top Court Says

The U.S. Supreme Court gave a new legal shield to the generic-drug industry, ruling that companies can’t be sued for failing to warn patients about the risk of dangerous side effects. The 5-4 ruling bars two women from suing units of Mylan Inc. and Teva Pharmaceutical Industries Ltd. over metoclopramide (Reglan), a stomach drug they say caused them to contract a severe neurological disorder.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.